Trial Profile
A study of alpha 7 nicotinic acetylcholine receptor (citicoline) for the assessment of cognitive effects in healthy male volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Feb 2016
Price :
$35
*
At a glance
- Drugs Citicoline (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 11 Feb 2016 New trial record